Repare Therapeutics Inc
NASDAQ:RPTX

Watchlist Manager
Repare Therapeutics Inc Logo
Repare Therapeutics Inc
NASDAQ:RPTX
Watchlist
Price: 2.81 USD -5.39% Market Closed
Market Cap: 119.5m USD
Have any thoughts about
Repare Therapeutics Inc?
Write Note

Relative Value

The Relative Value of one RPTX stock under the Base Case scenario is 4.08 USD. Compared to the current market price of 2.81 USD, Repare Therapeutics Inc is Undervalued by 31%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

RPTX Relative Value
Base Case
4.08 USD
Undervaluation 31%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
63
vs Industry
73
Median 3Y
4.2
Median 5Y
4.7
Industry
7.7
Forward
2
vs History
vs Industry
Median 3Y
-5.1
Median 5Y
-10.4
Industry
22.7
Forward
-1.2
vs History
vs Industry
0
Median 3Y
-2.4
Median 5Y
-4.5
Industry
21.6
vs History
vs Industry
Median 3Y
-4.3
Median 5Y
-5.9
Industry
25.2
vs History
81
vs Industry
66
Median 3Y
1.7
Median 5Y
2.2
Industry
2.5
vs History
vs Industry
85
Median 3Y
1.4
Median 5Y
1.5
Industry
7.7
Forward
-1.8
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
9
vs History
19
vs Industry
19
Median 3Y
-1.6
Median 5Y
-4.2
Industry
4.2
Forward
0.9
vs History
19
vs Industry
17
Median 3Y
-1.6
Median 5Y
-3.8
Industry
4.1
Forward
1
vs History
30
vs Industry
22
Median 3Y
-0.6
Median 5Y
-2
Industry
5.7
vs History
25
vs Industry
18
Median 3Y
-1.8
Median 5Y
-2.9
Industry
3.6
vs History
vs Industry
72
Median 3Y
6.1
Median 5Y
10
Industry
4.6

Multiples Across Competitors

RPTX Competitors Multiples
Repare Therapeutics Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Repare Therapeutics Inc
NASDAQ:RPTX
118.5m USD 2.3 -1.3 0.9 0.9
FR
Pharnext SCA
OTC:PNEXF
6T USD 38 083 264.3 -181 004.1 -219 796.6 -217 288.5
US
Abbvie Inc
NYSE:ABBV
312.7B USD 5.6 61.5 15.3 23.6
US
Amgen Inc
NASDAQ:AMGN
158.3B USD 4.9 37.4 17.5 33.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
116.2B USD 10.9 -242.3 24.1 25.3
US
Gilead Sciences Inc
NASDAQ:GILD
112.4B USD 4 891.9 9.9 9.9
US
Epizyme Inc
F:EPE
94.1B EUR 1 849.9 -472 -514.1 -500.3
AU
CSL Ltd
ASX:CSL
133.6B AUD 5.9 32.9 20.3 25.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
81.3B USD 5.9 17.5 15.9 17.7
US
Seagen Inc
F:SGT
39.3B EUR 17.8 -54.6 -58.7 -53
NL
argenx SE
XBRU:ARGX
34.8B EUR 18.7 -131 -105.5 -76.9
P/E Multiple
Earnings Growth
CA
Repare Therapeutics Inc
NASDAQ:RPTX
Average P/E: 208.2
Negative Multiple: -1.3
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -181 004.1 N/A
US
Abbvie Inc
NYSE:ABBV
61.5
412%
US
Amgen Inc
NASDAQ:AMGN
37.4
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -242.3
42%
US
Gilead Sciences Inc
NASDAQ:GILD
891.9
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -472 N/A
AU
CSL Ltd
ASX:CSL
32.9
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.5
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.6 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -131 N/A
EV/EBITDA Multiple
EBITDA Growth
CA
Repare Therapeutics Inc
NASDAQ:RPTX
Average EV/EBITDA: 14.8
0.9
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -219 796.6 N/A
US
Abbvie Inc
NYSE:ABBV
15.3
29%
US
Amgen Inc
NASDAQ:AMGN
17.5
62%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.1
43%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
16%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -514.1 N/A
AU
CSL Ltd
ASX:CSL
20.3
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.9
35%
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.7 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -105.5 N/A
EV/EBIT Multiple
EBIT Growth
CA
Repare Therapeutics Inc
NASDAQ:RPTX
Average EV/EBIT: 19.4
0.9
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -217 288.5 N/A
US
Abbvie Inc
NYSE:ABBV
23.6
88%
US
Amgen Inc
NASDAQ:AMGN
33.1
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.3
44%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -500.3 N/A
AU
CSL Ltd
ASX:CSL
25.3
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.7
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.9 N/A

See Also

Discover More
Back to Top